US pharmaceutical company faces SEC probe

The California-based Adamis Pharmaceuticals Corporation says it is under investigation by the US securities regulator – in addition to Manhattan federal prosecutors – over the sale of veterinary products.


Get unlimited access to all Global Investigations Review content